PhRMA Blog
13 FOLLOWERS
PhRMA Blog is a platform for the Pharmaceutical Research and Manufacturers of America to share their perspective on the latest issues and trends in drug discovery and development. The blog covers a wide range of topics, from clinical trials to intellectual property, and provides a forum for industry leaders to share their insights and opinions.
PhRMA Blog
4d ago
The industry is committed to delivering new, innovative medicines and working with policymakers to ensure they are accessible and affordable for patients through programs like Medicaid. ..read more
PhRMA Blog
4d ago
The accelerated approval pathway is making a positive difference in the lives of people facing life-threatening diseases and closing gaps in care for underserved communities ..read more
PhRMA Blog
4d ago
This AANHPI Heritage Month, the Asian & Pacific Islander American Health Forum (APIAHF) shines a light on a grave health disparity within these diverse groups ..read more
PhRMA Blog
4d ago
If policymakers want to fix the system and help patients, they need to pass reforms that take on the middlemen, realign incentives in the market, strengthen competition and improve patients’ access to care ..read more
PhRMA Blog
4d ago
As the public focus on new, innovative diabetes and anti-obesity medicines has increased, so have attempts by insurers and others to distort the facts about the potential costs to the health care system ..read more
PhRMA Blog
2w ago
Political posturing during the 2024 election season is injecting partisan politics into health care debates ..read more
PhRMA Blog
2w ago
Medicare beneficiaries are facing greater access restrictions on their lifesaving medicines ..read more
PhRMA Blog
2w ago
While Illinois lawmakers consider a “Health Care Availability and Access Board” (sometimes referred to as a prescription drug affordability board or PDAB), these boards are really code for government price-setting. Illinoisans should be concerned ..read more
PhRMA Blog
2w ago
A first-of-its-kind analysis found no evidence a new law requiring insurance companies and their pharmacy benefit managers (PBM) to share rebates with patients has an impact on premiums ..read more
PhRMA Blog
2w ago
Policy experts, providers and others have warned that Part D plans will likely restrict patient access to medicines because of the price setting and other provisions in the IRA ..read more